Vaborem® for Serious Infections in Children

We are studying how Vaborem® is processed in the body and its safety in children with suspected or confirmed Gram-negative infections. This trial includes kids from birth to under 18 years old.

≤3 months≤5 visitsEfficacy phase (II)No PlaceboPartially RemoteInvestigational MedicinesInjectionInfectious DiseasesPediatrics

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Meropenem
Meropenem is an antibiotic substance used to treat serious bacterial infections, including severe or hospital-acquired infections.
Vaborbactam
Vaborbactam is a substance that blocks bacterial enzymes that destroy some antibiotics, helping those antibiotics treat resistant infections.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Vaborem

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Fakultni Nemocnice Ostrava
Klinika dětského lékařství
Hlučín, Czechia
Fakultni Nemocnice Kralovske Vinohrady
Klinika dětí a dorostu
Prague, Czechia
Centre Hospitalier Regional Universitaire De Tours
Service Maladies Infectieuses et Tropicales
La Riche, France
Sponsor: Menarini Ricerche S.p.A.
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.